BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16175431)

  • 1. Remitting seronegative symmetrical synovitis with pitting edema in leprosy.
    Helling CA; Locursio A; Manzur ME; Sormani de Fonseca ML
    Clin Rheumatol; 2006 Feb; 25(1):95-7. PubMed ID: 16175431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging findings in a case of remitting seronegative symmetrical synovitis with pitting edema.
    Unlu Z; Orguc S; Ovali GY; Tarhan S; Dayan I; Angin A
    Clin Rheumatol; 2005 Nov; 24(6):648-51. PubMed ID: 15926037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome associated with bilateral pleural and pericardial effusions: a case report.
    Yanamoto S; Fukae J; Fukiyama Y; Fujioka S; Ouma S; Tsuboi Y
    J Med Case Rep; 2016 Jul; 10():198. PubMed ID: 27439425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report.
    Ngo L; Miller E; Valen P; Gertner E
    J Med Case Rep; 2018 Feb; 12(1):48. PubMed ID: 29478412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with multidrug therapy in paucibacillary leprosy.
    Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
    Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 7. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Hansen's disease.
    Alto WA
    Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
    [No Abstract]   [Full Text] [Related]  

  • 10. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 11. Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):135-9. PubMed ID: 945234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of leprosy today].
    Bahmer FA; Menzel S
    Hautarzt; 1987 Jan; 38(1):1-3. PubMed ID: 3557977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ominous sign of a disfiguring disease. Leprosy (Hansen's disease).
    Winter CA; Hsu S
    Postgrad Med; 2000 May; 107(5):87-9. PubMed ID: 10844944
    [No Abstract]   [Full Text] [Related]  

  • 14. Leprosy in the UK.
    Bharucha T; Lockwood D
    Br J Hosp Med (Lond); 2016 Oct; 77(10):C154-C156. PubMed ID: 27723400
    [No Abstract]   [Full Text] [Related]  

  • 15. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of WHO regimens in the management of leprosy patients with G6PD deficiency.
    Mysore V; al-Suwaid AR
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):159-61. PubMed ID: 10472369
    [No Abstract]   [Full Text] [Related]  

  • 17. Multi-drug therapy of leprosy.
    Ramu G
    Indian J Lepr; 1985; 57(3):465-82. PubMed ID: 2420903
    [No Abstract]   [Full Text] [Related]  

  • 18. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
    Levis WR; Spencer TI; Ladizinski B
    J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome): a report of two cases and review of the literature.
    Tunc SE; Arslan C; Ayvacioglu NB; Sahin M; Akkus S; Yorgancigil H
    Rheumatol Int; 2004 Jul; 24(4):234-7. PubMed ID: 14593491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.